The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
Hector Clarke, Shaker A MousaThe Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USAAbstract: One of the great advances in the treatment of HIV-1 infection was the development of the highly active antiretroviral therapy (HAART). Although this treatm...
Saved in:
Main Authors: | Hector Clarke (Author), Shaker A Mousa (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etiology of aggressive periodontitis in individuals of African descent
by: Akihiro Yoshida, et al.
Published: (2021) -
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
by: Christopher Barone, et al.
Published: (2009) -
Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data
by: Bianca Kruger, et al.
Published: (2024) -
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
by: Peter Avery, et al.
Published: (2009) -
Patterns of vitamin D, parathyroid hormone and c-terminal telopeptide of collagen type 1 in Caucasian and African descent HIV-infected populations in Central Europe
by: Sebastian Noe, et al.
Published: (2017)